Long-term clinical outcome after lyme neuroborreliosis in childhood

Pediatrics

Volumn 130, Issue 2, 2012, Pages 262-269

  Skogman, Barbro H ^a,b   Glimåker, Kajsa ^c   Nordwall, Maria ^c,d   Vrethem, Magnus ^c   Ödkvist, Lars ^c   Forsberg, Pia ^c  

^a FALUN HOSPITAL   (Sweden)

^b Center for Clinical Research in Dalarna (CKF)   (Sweden)

^c LINKÖPING UNIVERSITY   (Sweden)

^d VRINNEVI HOSPITAL   (Sweden)

Author keywords

Children; Clinical outcome; Facial nerve palsy; Lyme borreliosis; Neuroborreliosis; Persistent symptoms; Sequelae

Indexed keywords

ACADEMIC ACHIEVEMENT; ADOLESCENT; ADULT; ARTICLE; CHILD; CHILDHOOD; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONCENTRATION LOSS; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE SEVERITY; FACIAL NERVE PARALYSIS; FATIGUE; FEMALE; HEADACHE; HEMIFACIAL ATROPHY; HEMIPARESIS; HUMAN; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MEMORY DISORDER; NEUROLOGIC EXAMINATION; OUTCOME ASSESSMENT; PAIN; PARESTHESIA; PERONEUS NERVE PARALYSIS; POLYNEUROPATHY; PRESCHOOL CHILD; PRIORITY JOURNAL; QUESTIONNAIRE; RADICULOPATHY; SCHOOL CHILD; SYMPTOM; TRIGEMINUS NEURALGIA; VERTIGO;

EID: 84864524102     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2011-3719     Document Type: Article

References (35)

1. Stanek G, Strle F. Lyme borreliosis. Lancet. 2003;362(9396):1639-1647 (Pubitemid 37443533)
2. Steere AC. Lyme borreliosis in 2005, 30 years after initial observations in Lyme Connecticut. Wien Klin Wochenschr. 2006; 118(21-22):625-633 (Pubitemid 44953963)
3. Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43(9):1089-1134 (Pubitemid 44637131)
4. Eppes SC. Diagnosis, treatment, and prevention of Lyme disease in children. Paediatr Drugs. 2003;5(6):363-372 (Pubitemid 36745668)
5. Christen HJ, Hanefeld F, Eiffert H, Thomssen R. Epidemiology and clinical manifestations of Lyme borreliosis in childhood. A prospective multicentre study with special regard to neuroborreliosis. Acta Paediatr Suppl. 1993; 386:1-75 (Pubitemid 23072307)
6. Øymar K, Tveitnes D. Clinical characteristics of childhood Lyme neuroborreliosis in an endemic area of northern Europe. Scand J Infect Dis. 2009;41(2):88-94
7. Feder HM Jr. Lyme disease in children. Infect Dis Clin North Am. 2008;22(2):315-326 vii
8. Broekhuijsen-van Henten DM, Braun KP, Wolfs TF. Clinical presentation of childhood neuroborreliosis; neurological examination may be normal. Arch Dis Child. 2010;95(11): 910-914
9. Stanek G, O'Connell S, Cimmino M, et al. European Union Concerted Action on Risk Assessment in Lyme Borreliosis: clinical case definitions for Lyme borreliosis. Wien Klin Wochenschr. 1996;108(23):741-747 (Pubitemid 26422955)
10. Stanek G, Fingerle V, Hunfeld KP, et al. Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. Clin Microbiol Infect. 2011;17(1):69-79
11. Mygland A, Ljostad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol. 2010;17(1):8-16, e11-e14
12. Tveitnes D, Øymar K, Natås O. Laboratory data in children with Lyme neuroborreliosis, relation to clinical presentation and duration of symptoms. Scand J Infect Dis. 2009;41(5): 355-362
13. Skogman BH, Croner S, Nordwall M, Eknefelt M, Ernerudh J, Forsberg P. Lyme neuroborreliosis in children: a prospective study of clinical features, prognosis, and outcome. Pediatr Infect Dis J. 2008;27(12):1089-1094
14. Ljøstad U, Skogvoll E, Eikeland R, et al. Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial. Lancet Neurol. 2008;7(8):690-695
15. Thorstrand C, Belfrage E, Bennet R, Malmborg P, Eriksson M. Successful treatment of neuroborreliosis with ten day regimens. Pediatr Infect Dis J. 2002;21(12):1142-1145 (Pubitemid 35463031)
16. O'Connell S. Lyme borreliosis: current issues in diagnosis and management. Curr Opin Infect Dis. 2010;23(3):231-235
17. Berglund J, Stjernberg L, Ornstein K, Tykesson-Joelsson K, Walter H. 5-y Follow-up study of patients with neuroborreliosis. Scand J Infect Dis. 2002;34(6):421-425 (Pubitemid 34823436)
18. Skogman BH, Croner S, Odkvist L. Acute facial palsy in children - a 2-year follow-up study with focus on Lyme neuroborreliosis. Int J Pediatr Otorhinolaryngol. 2003;67(6):597-602 (Pubitemid 36549067)
19. Peltomaa M, Saxen H, Seppälä I, Viljanen M, Pyykkö I. Paediatric facial paralysis caused by Lyme borreliosis: a prospective and retrospective analysis. Scand J Infect Dis. 1998;30(3):269-275 (Pubitemid 28461597)
20. Bagger-Sjöbäck D, Remahl S, Ericsson M. Long-term outcome of facial palsy in neuroborreliosis. Otol Neurotol. 2005;26(4): 790-795 (Pubitemid 41026115)
21. Vrethem M, Hellblom L, Widlund M, et al. Chronic symptoms are common in patients with neuroborreliosis - a questionnaire follow-up study. Acta Neurol Scand. 2002; 106(4):205-208
22. Halperin JJ, Shapiro ED, Logigian E, et al; Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2007;69(1):91-102 (Pubitemid 47025211)
23. Fallon BA, Keilp JG, Corbera KM, et al. A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology. 2008;70(13):992-1003 (Pubitemid 351451323)
24. Adams WV, Rose CD, Eppes SC, Klein JD. Cognitive effects of Lyme disease in children: a 4 year follow-up study. J Rheumatol. 1999;26(5):1190-1194 (Pubitemid 29215089)
25. Vázquez M, Sparrow SS, Shapiro ED. Longterm neuropsychologic and health outcomes of children with facial nerve palsy attributable to Lyme disease. Pediatrics. 2003;112(2). Available at: www.pediatrics.org/cgi/content/ full/112/2/e93
26. Hansen K, Lebech AM. Lyme neuroborreliosis: a new sensitive diagnostic assay for intrathecal synthesis of Borrelia burgdorferi - specific immunoglobulin G, A, and M. Ann Neurol. 1991;30(2):197-205
27. House JW, Brackmann DE. Facial nerve grading system. Otolaryngol Head Neck Surg. 1985;93(2):146-147 (Pubitemid 15064413)
28. Wang TJ, Sangha O, Phillips CB, et al. Outcomes of children treated for Lyme disease. J Rheumatol. 1998;25(11):2249-2253 (Pubitemid 28505876)
29. Peltomaa M, Pyykkö I, Seppälä I, Viljanen M. Lyme borreliosis - an unusual cause of vertigo. Auris Nasus Larynx. 1998;25(3): 233-242 (Pubitemid 28440582)
30. Kowalski TJ, Berth WL, Mathiason MA, Agger WA. Oral antibiotic treatment and long-term outcomes of Lyme facial nerve palsy. Infection. 2011;39(3):239-245
31. Borg R, Dotevall L, Hagberg L, et al. Intravenous ceftriaxone compared with oral doxycycline for the treatment of Lyme neuroborreliosis. Scand J Infect Dis. 2005;37(6-7): 449-454 (Pubitemid 41038515)
32. Halperin JJ. Neurologic manifestations of lyme disease. Curr Infect Dis Rep. 2011;13 (4):360-366
33. Seltzer EG, Gerber MA, Cartter ML, Freudigman K, Shapiro ED. Long-term outcomes of persons with Lyme disease. JAMA. 2000; 283(5):609-616 (Pubitemid 30069176)
34. Eikeland R, Mygland A, Herlofson K, Ljøstad U. European neuroborreliosis: quality of life 30 months after treatment. Acta Neurol Scand. 2011;124(5):349-354
35. Djukic M, Schmidt-Samoa C, Nau R, von Steinbüchel N, Eiffert H, Schmidt H. The diagnostic spectrum in patients with suspected chronic Lyme neuroborreliosis - the experience from one year of a university hospital's Lyme neuroborreliosis outpatients clinic. Eur J Neurol. 2011;18(4):547-555